SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-009097
Filing Date
2021-08-16
Accepted
2021-08-16 16:48:00
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT azrx_10q.htm   iXBRL 10-Q 1204513
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF azrx_ex311.htm EX-31.1 9925
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF azrx_ex312.htm EX-31.2 9916
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE azrx_ex321.htm EX-32.1 4657
  Complete submission text file 0001654954-21-009097.txt   6867476

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA azrx-20210630.xsd EX-101.SCH 83531
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20210630_cal.xml EX-101.CAL 52834
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20210630_def.xml EX-101.DEF 276273
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20210630_lab.xml EX-101.LAB 467786
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20210630_pre.xml EX-101.PRE 401131
10 EXTRACTED XBRL INSTANCE DOCUMENT azrx_10q_htm.xml XML 1091270
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 211179262
SIC: 2834 Pharmaceutical Preparations